Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Product not yet rated Contains 2 Component(s)

    Webinar hosted by the Women's Initiatives Committee on Tuesday, December 13, 2022.

    The purpose of this webinar is to discuss the issues facing women who wish to pursue an academic career in Hepatology. The idea behind is that examining the obstacles and the difficulties will help in identifying the possible solutions.

    The webinar will start with the trailer of the very relevant documentary “Picture a Scientist” as an introduction to formal presentations, which will examine the problem of academic disadvantage, both in terms of poor recognition of career progression and authorship. Two lectures will be an exemplification of real careers by a junior and a senior faculty member, and lastly a lecture will be devoted to identify possible resources.

    There will then be a 20-minute discussion between panelists and a Q and A session to involve the audience, directed by our moderator.

    Erica Villa (Moderator)

    Professor of Gastroenterology

    University of Modena and Reggio Emilia

    Tatyana Kushner (Moderator)

    Associate Professor, Division of Liver Diseases

    Icahn School of Medicine at Mount Sinai

    Tatyana Kushner, MD, MSCE, is Assistant Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai in New York. She completed her medical school and internal medicine training at Mount Sinai School of Medicine, a fellowship in gastroenterology and a masters in clinical epidemiology at the University of Pennsylvania, and a fellowship in transplant hepatology at the University of California, San Francisco (UCSF). Her research focuses on both epidemiologic and patient-centered outcomes in viral hepatitis, with an emerging focus in the area of women’s health and pregnancy care, and the goal of developing and studying interventions to improve clinical outcomes in this patient population. She has recently established a Women's Liver Clinic at Mount Sinai in order to enhance the diagnosis and management of liver disease during pregnancy and post-delivery, particularly of hepatitis B and hepatitis C. 

     

    Monika Sarkar (Moderator)

    Marina Berenguer

    Guadalupe Garcia-Tsao

    Guadalupe Garcia-Tsao, MD, FAASLD is Professor of Medicine, Chief of Digestive Diseases and Program Director of the Hepatitis C Resource Center at Veteran’s Administration-Connecticut Healthcare System, as well as Director of Clinical and Translational Core at Yale Liver Center. She is a past president of AASLD. She received her M.D. and training at Universidad Nacional Autónoma de Mexico. Her primary research focus is on clinical research which focuses on cirrhosis and its complications, and she also is involved in the study of bacterial infections in cirrhosis, a complication that is often overlooked.

    Kathleen E. Corey

    Kathleen E. Corey, MD, MPH, MMSc is the Director of the MGH Non-Alcoholic Fatty Liver Disease (NAFLD) Clinic, Associate Program Director for the Medicine Residency for Clinical and Translational Research, a hepatologist who specializes in NAFLD, Physician Investigator in the CTEU, and an Assistant Professor of Medicine at HMS.

     Dr. Corey’s interests include clinical and translational research in NAFLD. She aims to better understand predictors of development and progression of NAFLD, the interplay between cardiovascular disease and NAFLD and the natural history of NAFLD in persons living with HIV (PLWH). She is the Co-PI for an R01 evaluating the role of tesamorelin, a growth hormone-releasing hormone for the treatment of NAFLD and is involved in an NIH-funded study on the prevalence, risk factors and treatment of NAFLD in PLWH.

     Dr. Corey earned her MD at Duke University School of Medicine, her MPH from the University of North Carolina and her MMSc from Harvard Medical School. Prior to joining the faculty of MGH, she completed her training in Internal Medicine, Chief Residency, Gastroenterology and Advanced Hepatology and Liver Transplant at MGH.

    Rotonya Carr, MD

    Anita Chong, PhD

  • Contains 2 Component(s)

    Webinar hosted by the Hypertension SIG on Monday, December 12, 2022.

    There is emerging data showing benefits of diagnosing clinically significant portal hypertension and its treatment to prevent decompensation. The field is rapidly evolving, specifically with respect to non-invasive modalities of measurement. This webinar will review currently available non-invasive tests to measure clinically significant portal hypertension including blood tests, liver stiffness and spleen stiffness. Use of non-invasive measurements in special populations such as those with fatty liver disease and those who have achieved sustained virological response as well as how to monitor improvements in clinically significant portal hypertension without ongoing injury are also areas of interest which will be addressed.

    There will then be a 20-minute discussion between panelists and a Q and A session to involve the audience, directed by our moderator.

    Maja Thiele, MD, PhD

    Dr. Maja Thiele works to reduce morbidity and mortality from alcohol-related liver disease, for the benefit of an otherwise stigmatized patient group. Her research centers on the development and validation of diagnostic and prognostic biomarkers, with a particular focus on early disease detection, cost-effective referral pathways and omics technologies. Elastography expert contributor to EASL Clinical Practice Guidance, the BAVENO VII consensus statement, and AASLD clinical guidance. Partner in the European research consortia GALAXY, LiverScreen, MicrobPredict and SALVE.

    Annalisa Berzigotti

    Annalisa Berzigotti graduated in Medicine in Bologna, Italy, where she also obtained the title of specialist in Internal Medicine and a Doctorate in ultrasound in medicine. She expanded her knowledge in hepatology at the Hepatic hemodynamic Laboratory of the Liver Unit of the Hospital Clinic, University of Barcelona, Spain, where she obtained a Doctorate in hepatology. In December 2014 she joined the hepatology group of the Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Switzerland. Since March 2021 she is chief of the liver group and ad interim clinic director at the Department of Visceral Surgery and Medicine, Bern University Hospital.  Annalisa Berzigotti has been member of the Governing Board of the European Association for the Study of the Liver in 2016-2019. Since 2022 she is Liver Representative at the United European Gastroenterology (UEG) Council. She is Associate Editor of the Journal of Hepatology and of Seminars in Liver Disease. Her main research interests include portal hypertension and non-invasive assessment of liver disease.

    Atoosa Rabiee, MD

    Annalisa Berzigotti graduated in Medicine in Bologna, Italy, where she also obtained the title of specialist in Internal Medicine and a Doctorate in ultrasound in medicine. She expanded her knowledge in hepatology at the Hepatic hemodynamic Laboratory of the Liver Unit of the Hospital Clinic, University of Barcelona, Spain, where she obtained a Doctorate in hepatology. In December 2014 she joined the hepatology group of the Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Switzerland. Since March 2021 she is chief of the liver group and ad interim clinic director at the Department of Visceral Surgery and Medicine, Bern University Hospital.  Annalisa Berzigotti has been member of the Governing Board of the European Association for the Study of the Liver in 2016-2019. Since 2022 she is Liver Representative at the United European Gastroenterology (UEG) Council. She is Associate Editor of the Journal of Hepatology and of Seminars in Liver Disease. Her main research interests include portal hypertension and non-invasive assessment of liver disease.

  • Product not yet rated Contains 4 Component(s)

    A series of debriefs covering leading topics from abstracts presented at The Liver Meeting 2022 in Washington, D.C.

    A series of debriefs covering leading topics from abstracts presented at The Liver Meeting 2022 in Washington, D.C.

    Topics include:

    • Basic Science
    • Hepatitis
    • NAFLD
    • Portal Hypertension
  • Product not yet rated Contains 3 Product(s)

    View on-demand presentations from The Liver Meeting® 2022.

    View on-demand presentations from The Liver Meeting® 2022. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. 

  • Product not yet rated Contains 4 Component(s)

    A collection of lectures covering the state of the art in liver medicine

    A collection of lectures covering the state of the art in liver medicine, originally presented at The Liver Meeting 2022 in Washington, D.C.

    Lectures include: 

    • Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture, Normothermic Liver Perfusion to Improve Early Allograft Function
    • Leon Schiff State-of-the-Art Lecture, The evolution of disease modeling in NAFLD
    • Hans Popper State-of-the-Art Lecture, Human Organoids Toward Precision Hepatology
    • Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture, Mechanisms of Drug-induced Liver Injury
  • Product not yet rated Contains 17 Component(s)

    Programming from TLM 2022 hosted by AASLD's Special Interest Groups

    Programming from TLM 2022 hosted by AASLD's Special Interest Groups. Programs include:

    • ACLF and Clinical Practice
    • ALD and NAFLD
    • Applications in Public Health
    • Cholestatic & Autoimmune and Liver Transplant
    • Hepatitis B
    • Hepatitis C
    • Hepatology Associates
    • Hepatotoxicity
    • Liver Cancer and Pediatrics
    • Liver Fibrosis
    • Pediatric Liver Disorders
    • Portal Hypertension
  • Product not yet rated Contains 2 Component(s)

    The emerging topic conference occurred on October 1st & 2nd, 2022. After completing this activity, you should be able to: • Define and list disparities that are present in chronic liver disease and liver transplantation. • Construct and design strategies around palliative care implementation in chronic liver disease management. • Develop and present strategies to eliminate disparities in chronic liver disease management.

    There has been increasing national awareness of systemic racism and oppression of communities of color in the United States. Systemic racism negatively impacts health outcomes and has also played a role in decreased access to specialty care, liver transplant waitlist, receipt of liver transplantation and post-transplant outcomes. Patients of color are disproportionately less likely to be listed for liver transplant or to undergo transplantation. This webinar is intended to increase awareness of the barriers patients experience in the liver transplant process and propose strategies to increase access to liver transplant.

  • Contains 9 Component(s)

    Recordings from the AASLD/EASL NAFLD Nomenclature Consensus Conference can be accessed here. The conference took place July 8-9, 2022 in Chicago, IL and virtually.

    Recordings from the AASLD/EASL NAFLD Nomenclature Consensus Conference can be accessed here. The conference took place July 8-9, 2022 in Chicago, IL and virtually.

  • Contains 2 Component(s)

    Webinar hosted by the Clinical Practice Special Interest Group on Thursday, September 15, 2022.

    Ascites is a common complication and often the first sign of decompensation in patients with End-Stage Liver Disease. Management of ascites is often fraught with complex challenges including electrolyte imbalances, renal failure, hepatic encephalopathy, and significant utilization of resources. A proportion of the patients do not respond to conventional diuretic therapy (refractory ascites) or develop significant side effects that limit the diuretics' optimal dosing, leading to suboptimal control of ascites ( intractable ascites). This webinar will review recent advances in managing refractory/intractable ascites.

  • Contains 2 Component(s)

    Webinar hosted by the Clinical Practice Special Interest Group on Thursday, July 14, 2022.

    Management of autoimmune hepatitis is often quite complex, especially for those not achieving remission with conventional immunosuppression. This webinar aims to review current and upcoming pharmacological treatment options in the management of these special groups of patients.